Cargando…

MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL)

Cervical cancer is the fourth most common malignancy among females worldwide. MicroRNA-379 (miR-379) is aberrantly expressed in multiple human cancer types. However, the expression pattern, roles, and detailed regulatory mechanisms of miR-379 in cervical cancer remain unknown. In this study, we foun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xi, Xiao, Xiao, Yuan, Na, Zhang, Shili, Yuan, Fukang, Wang, Xiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844644/ https://www.ncbi.nlm.nih.gov/pubmed/29295725 http://dx.doi.org/10.3727/096504017X15140534417184

Ejemplares similares

Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021)

Capability of the viral NS1 proteins to bind to the cellular adaptor proteins Crk and CrkL determines sensitivity of influenza viruses to Crk/CrkL expression
por: Hrincius, ER, et al.
Publicado: (2009)

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling
por: Birge, Raymond B, et al.
Publicado: (2009)

Bifunctional Role of CrkL during Bone Remodeling
por: Kim, Jung Ha, et al.
Publicado: (2021)

Domain organization differences explain Bcr-Abl’s preference for CrkL over CrkII
por: Jankowski, Wojciech, et al.
Publicado: (2012)

Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development
por: Wu, Bingruo, et al.
Publicado: (2023)

Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity
por: Park, Taeju, et al.
Publicado: (2021)

CrkL is required for donor T cell migration to GvHD target organs
por: Roy, Nathan H., et al.
Publicado: (2020)

Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis
por: George, Britta, et al.
Publicado: (2014)

Sorbs1 and -2 Interact with CrkL and Are Required for Acetylcholine Receptor Cluster Formation
por: Hallock, Peter T., et al.
Publicado: (2016)

Increased Soluble CrkL in Serum of Breast Cancer Patients Is Associated with Advanced Disease
por: Srinivasan, Srimeenakshi, et al.
Publicado: (2019)

Phosphorylation of CrkL S114 induced by common gamma chain cytokines and T-cell receptor signal transduction
por: Estrada, Armando, et al.
Publicado: (2021)

Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design
por: Panigrahi, Soumya, et al.
Publicado: (2012)

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
por: Kim, Young H., et al.
Publicado: (2009)

CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015)

Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation
por: Zheng, Ji, et al.
Publicado: (2010)

The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL–C3G-mediated activation of Rap1
por: Nolz, Jeffrey C., et al.
Publicado: (2008)

Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling
por: Yu, Jiang, et al.
Publicado: (2021)

Proto-oncogene CT10-regulated kinase (CRK) is a pro-apoptotic transducer of endoplasmic reticulum stress
por: Austgen, Kathryn, et al.
Publicado: (2011)

Crk gets hijacked
por: Van Epps, Heather L.
Publicado: (2005)

Cracking Cancer with CRK
por: Uthamacumaran, Abicumaran, et al.
Publicado: (2009)

MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
por: Li, Zheng, et al.
Publicado: (2016)

Expression of microRNA-379 reduces metastatic spread of prostate cancer
por: Cassidy, James R., et al.
Publicado: (2023)

Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer
por: Zhang, Jia-kui, et al.
Publicado: (2017)

Prognostic value of microRNA-126 and CRK expression in gastric cancer
por: Yue, Shun, et al.
Publicado: (2016)

CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell
por: Song, Qingling, et al.
Publicado: (2019)

Follicle-stimulating hormone inhibits cervical cancer via NF-κB pathway
por: Shi, Xi, et al.
Publicado: (2018)

Folding and Binding Mechanisms of the SH2 Domain from Crkl
por: Nardella, Caterina, et al.
Publicado: (2022)

Immunohistochemichal Assessment of the CrkII Proto-oncogene Expression in Common Malignant Salivary Gland Tumors and Pleomorphic Adenoma
por: Askari, Mitra, et al.
Publicado: (2015)

SAT-379 Giant Parathyroid Adenoma
por: Saberi, Sima, et al.
Publicado: (2020)

MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
por: Xie, Xi, et al.
Publicado: (2017)

Surgical Outcomes of Selective Laminectomy for Patients With Cervical Kyphosis: A Retrospective Study of 379 Cases
por: Ninomiya, Ken, et al.
Publicado: (2021)

CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma
por: Cai, Le, et al.
Publicado: (2017)

Genome-Wide Identification and Functional Analyses of the CRK Gene Family in Cotton Reveals GbCRK18 Confers Verticillium Wilt Resistance in Gossypium barbadense
por: Li, Ting-Gang, et al.
Publicado: (2018)

Copy number gains of the putative CRKL oncogene in laryngeal squamous cell carcinoma result in strong nuclear expression of the protein and influence cell proliferation and migration
por: Kostrzewska-Poczekaj, Magdalena, et al.
Publicado: (2020)

MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
por: Zhao, Yue, et al.
Publicado: (2017)

c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells
por: Mortazavi, Fariborz, et al.
Publicado: (2011)

MicroRNA-215-5p Inhibits the Proliferation and Migration of Wilm’s Tumor Cells by Targeting CRK
por: Li, Wang, et al.
Publicado: (2021)

MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation
por: Wang, Yuan, et al.
Publicado: (2015)

CRKL is a critical target of Hh‐GLI2 pathway in lung adenocarcinoma
por: Liu, Xiaoming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvsjbjpdmm6qmr4uthsmu43uq8